

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding corticotroph... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1354/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1354" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding corticotroph pituitary tumor initiation and progression" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding corticotroph pituitary tumor initiation and progression.">
            <meta name="og:description" content="Read the latest article version by Ulrich Renner, Denis Ciato, G&uuml;nter K. Stalla, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="16094">
            <meta name="article-id" content="14789">
            <meta name="dc.title" content="Recent advances in understanding corticotroph pituitary tumor initiation and progression">
            <meta name="dc.description" content="Cushing&rsquo;s disease is the most frequent form of hypercortisolism and is caused by hypophyseal corticotroph adenomas secreting excessive amounts of adrenocorticotropic hormone. Most of the tumors develop sporadically and only a limited number of corticotroph adenomas have been found to be associated with different neuroendocrine syndromes or with familial isolated pituitary adenomas. The pathogenic mechanisms of corticotroph adenomas are largely unknown, but the discovered aberrant chaperoning activity of heat shock protein 90 on the one hand and the presence of ubiquitin-specific protease 8 mutations on the other hand partially explained the causes of their development. Corticotroph tumors arise initially as benign microadenomas but with time form invasively growing aggressive macroadenomas which can switch to corticotroph carcinomas in extremely rare cases. The mechanisms through which corticotroph tumors escape from glucocorticoid negative feedback are still poorly understood, as are the processes that trigger the progression of benign corticotroph adenomas toward aggressive and malignant phenotypes. This review summarizes recent findings regarding initiation and progression of corticotroph pituitary tumors.">
            <meta name="dc.subject" content="corticotroph tumor, USP8 mutation, progression, corticotroph carcinoma">
            <meta name="dc.creator" content="Renner, Ulrich">
            <meta name="dc.creator" content="Ciato, Denis">
            <meta name="dc.creator" content="Stalla, G&uuml;nter K.">
            <meta name="dc.date" content="2018/08/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14789.1">
            <meta name="dc.source" content="F1000Research 2018 7:1354">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="corticotroph tumor">
            <meta name="prism.keyword" content="USP8 mutation">
            <meta name="prism.keyword" content="progression">
            <meta name="prism.keyword" content="corticotroph carcinoma">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/08/29">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1354">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14789.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1354">
            <meta name="citation_title" content="Recent advances in understanding corticotroph pituitary tumor initiation and progression">
            <meta name="citation_abstract" content="Cushing&rsquo;s disease is the most frequent form of hypercortisolism and is caused by hypophyseal corticotroph adenomas secreting excessive amounts of adrenocorticotropic hormone. Most of the tumors develop sporadically and only a limited number of corticotroph adenomas have been found to be associated with different neuroendocrine syndromes or with familial isolated pituitary adenomas. The pathogenic mechanisms of corticotroph adenomas are largely unknown, but the discovered aberrant chaperoning activity of heat shock protein 90 on the one hand and the presence of ubiquitin-specific protease 8 mutations on the other hand partially explained the causes of their development. Corticotroph tumors arise initially as benign microadenomas but with time form invasively growing aggressive macroadenomas which can switch to corticotroph carcinomas in extremely rare cases. The mechanisms through which corticotroph tumors escape from glucocorticoid negative feedback are still poorly understood, as are the processes that trigger the progression of benign corticotroph adenomas toward aggressive and malignant phenotypes. This review summarizes recent findings regarding initiation and progression of corticotroph pituitary tumors.">
            <meta name="citation_description" content="Cushing&rsquo;s disease is the most frequent form of hypercortisolism and is caused by hypophyseal corticotroph adenomas secreting excessive amounts of adrenocorticotropic hormone. Most of the tumors develop sporadically and only a limited number of corticotroph adenomas have been found to be associated with different neuroendocrine syndromes or with familial isolated pituitary adenomas. The pathogenic mechanisms of corticotroph adenomas are largely unknown, but the discovered aberrant chaperoning activity of heat shock protein 90 on the one hand and the presence of ubiquitin-specific protease 8 mutations on the other hand partially explained the causes of their development. Corticotroph tumors arise initially as benign microadenomas but with time form invasively growing aggressive macroadenomas which can switch to corticotroph carcinomas in extremely rare cases. The mechanisms through which corticotroph tumors escape from glucocorticoid negative feedback are still poorly understood, as are the processes that trigger the progression of benign corticotroph adenomas toward aggressive and malignant phenotypes. This review summarizes recent findings regarding initiation and progression of corticotroph pituitary tumors.">
            <meta name="citation_keywords" content="corticotroph tumor, USP8 mutation, progression, corticotroph carcinoma">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Ulrich Renner">
            <meta name="citation_author_institution" content="Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany">
            <meta name="citation_author" content="Denis Ciato">
            <meta name="citation_author_institution" content="Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany">
            <meta name="citation_author" content="G&uuml;nter K. Stalla">
            <meta name="citation_author_institution" content="Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany">
            <meta name="citation_publication_date" content="2018/08/29">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1354">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14789.1">
            <meta name="citation_firstpage" content="1354">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1354/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1354.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=16094 /> <input type=hidden id=articleId name=articleId value=14789 /> <input type=hidden id=xmlUrl value="/articles/7-1354/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1354-v1.xml"> <input type=hidden id=article_uuid value=f527abc7-792b-45e5-8880-857ab84c732a /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding corticotroph pituitary tumor initiation and progression"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14789.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14789.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1354"
  },
  "headline": "Recent advances in understanding corticotroph pituitary tumor initiation and progression",
  "datePublished": "2018-08-29T16:13:44",
  "dateModified": "2018-08-29T16:13:44",
  "author": [
    {
      "@type": "Person",
      "name": "Ulrich Renner"
    },    {
      "@type": "Person",
      "name": "Denis Ciato"
    },    {
      "@type": "Person",
      "name": "G&uuml;nter K. Stalla"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Cushing&rsquo;s disease is the most frequent form of hypercortisolism and is caused by hypophyseal corticotroph adenomas secreting excessive amounts of adrenocorticotropic hormone. Most of the tumors develop sporadically and only a limited number of corticotroph adenomas have been found to be associated with different neuroendocrine syndromes or with familial isolated pituitary adenomas. The pathogenic mechanisms of corticotroph adenomas are largely unknown, but the discovered aberrant chaperoning activity of heat shock protein 90 on the one hand and the presence of ubiquitin-specific protease 8 mutations on the other hand partially explained the causes of their development. Corticotroph tumors arise initially as benign microadenomas but with time form invasively growing aggressive macroadenomas which can switch to corticotroph carcinomas in extremely rare cases. The mechanisms through which corticotroph tumors escape from glucocorticoid negative feedback are still poorly understood, as are the processes that trigger the progression of benign corticotroph adenomas toward aggressive and malignant phenotypes. This review summarizes recent findings regarding initiation and progression of corticotroph pituitary tumors."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1354",
            "name": "Recent advances in understanding corticotroph pituitary tumor initiation..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding corticotroph pituitary tumor initiation... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=16094 data-id=14789 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14789.1" data-recommended="" data-doi="10.12688/f1000research.14789.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1354/v1/pdf?article_uuid=f527abc7-792b-45e5-8880-857ab84c732a" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14789-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14789-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14789-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Renner U, Ciato D and Stalla GK. Recent advances in understanding corticotroph pituitary tumor initiation and progression [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1354 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14789.1" target=_blank>https://doi.org/10.12688/f1000research.14789.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14789-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14789 id=track-article-signin-14789 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14789?target=/articles/7-1354">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16094 /> <input name=articleId type=hidden value=14789 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding corticotroph pituitary tumor initiation and progression</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:renner@mpipsykl.mpg.de" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Ulrich Renner</span></a><a href="https://orcid.org/0000-0002-6172-231X" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6172-231X</div>,&nbsp;</span><span class="">Denis Ciato<a href="https://orcid.org/0000-0003-1563-3313" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1563-3313</div>,&nbsp;</span><span class="">G&uuml;nter K. Stalla</span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:renner@mpipsykl.mpg.de" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Ulrich Renner</span></a><a href="http://orcid.org/0000-0002-6172-231X" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6172-231X</div>,&nbsp;</span><span class="">Denis Ciato<a href="http://orcid.org/0000-0003-1563-3313" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1563-3313</div>,&nbsp;</span><span class="">G&uuml;nter K. Stalla</span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Aug 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14789.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany<br/> <p> <div class=margin-bottom> Ulrich Renner <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation </div> <div class=margin-bottom> Denis Ciato <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> G&uuml;nter K. Stalla <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=38326-37538></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=38324-37539></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Cushings disease is the most frequent form of hypercortisolism and is caused by hypophyseal corticotroph adenomas secreting excessive amounts of adrenocorticotropic hormone. Most of the tumors develop sporadically and only a limited number of corticotroph adenomas have been found to be associated with different neuroendocrine syndromes or with familial isolated pituitary adenomas. The pathogenic mechanisms of corticotroph adenomas are largely unknown, but the discovered aberrant chaperoning activity of heat shock protein 90 on the one hand and the presence of ubiquitin-specific protease 8 mutations on the other hand partially explained the causes of their development. Corticotroph tumors arise initially as benign microadenomas but with time form invasively growing aggressive macroadenomas which can switch to corticotroph carcinomas in extremely rare cases. The mechanisms through which corticotroph tumors escape from glucocorticoid negative feedback are still poorly understood, as are the processes that trigger the progression of benign corticotroph adenomas toward aggressive and malignant phenotypes. This review summarizes recent findings regarding initiation and progression of corticotroph pituitary tumors. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> corticotroph tumor, USP8 mutation, progression, corticotroph carcinoma </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Ulrich Renner (<a href="mailto:renner@mpipsykl.mpg.de">renner@mpipsykl.mpg.de</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Ulrich Renner </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by German Research Council (DFG). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Renner U <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Renner U, Ciato D and Stalla GK. Recent advances in understanding corticotroph pituitary tumor initiation and progression [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1354 (<a href="https://doi.org/10.12688/f1000research.14789.1" target=_blank>https://doi.org/10.12688/f1000research.14789.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Aug 2018, <b>7</b>(F1000 Faculty Rev):1354 (<a href="https://doi.org/10.12688/f1000research.14789.1" target=_blank>https://doi.org/10.12688/f1000research.14789.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Aug 2018, <b>7</b>(F1000 Faculty Rev):1354 (<a href="https://doi.org/10.12688/f1000research.14789.1" target=_blank>https://doi.org/10.12688/f1000research.14789.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d8163e167>Introduction</h2><p class="" id=d8163e170>Corticotroph adenomas (CAs) derive from normal corticotroph cells of the anterior pituitary and account for about 4% to 8% of all clinically hormone-active anterior pituitary tumor types<sup><a href="#ref-1">1</a></sup>. Including clinically inactive silent corticotroph tumors, CAs encompass up to 15% of all pituitary tumors<sup><a href="#ref-2">2</a></sup>. The prevalence for hormone-active CAs is about 40 cases per million and the incidence ranges from 1.2 to 2.4 per million per year. In adults, CAs are diagnosed mainly in the fourth to sixth decade of life and are about three times more prevalent in women<sup><a href="#ref-1">1</a></sup>. No gender preference has been observed in CAs in children, in whom these tumors are rare (&lt;10% of all CAs)<sup><a href="#ref-3">3</a></sup>.</p><p class="" id=d8163e189>CAs have rarely been described with hereditary background, and in the vast majority of sporadic CAs, the genetic background is still largely unknown<sup><a href="#ref-4">4</a></sup>. Whereas silent CAs are immunopositive for adrenocorticotropic hormone (ACTH), but do not manifest biochemical or clinical hypercortisolism<sup><a href="#ref-5">5</a></sup>, the majority of clinically active CAs secrete excessive amounts of ACTH, causing chronic hypercortisolism due to lack of hypothalamuspituitaryadrenal (HPA) axis feedback regulation at the level of the CA, leading to manifestations of the clinical features of Cushings disease<sup><a href="#ref-1">1</a></sup>. Normally, there is a delay of several years between the onset of the disease and its diagnosis because early symptoms of Cushings disease are rather unspecific. At the time of diagnosis, about 90% of the patients present with corticotroph microadenomas less than 1 cm in diameter; in some cases, these tumors are hardly detectable with magnetic resonance imaging<sup><a href="#ref-1">1</a></sup>. Transsphenoidal surgery is generally the initial treatment of choice but is not always successful. In the case of incomplete resection (for example, if the tumor is critically located in proximity to the optical nerves), the tumor might expand and become more aggressive over time, requiring repeated surgery, radiotherapy, pharmaceutical therapy, or adrenalectomy<sup><a href="#ref-1">1</a></sup>. In rare cases, CAs finally transform to metastasizing corticotroph carcinomas for which temozolomide treatment has recently been established with some success in single cases<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8163e223>Genetics of hereditary corticotroph adenomas</h2><p class="" id=d8163e226>Less than 5% of all CAs are familial adenomas representing rare tumor manifestations in various hereditary endocrine syndromesmultiple endocrine neoplasia 1 (MEN1), MEN4, Carney complex (CNC), and DICER1 syndromeor in familial isolated pituitary adenomas (FIPAs)<sup><a href="#ref-4">4</a>,<a href="#ref-8">8</a></sup>. Patients with MEN1, which is caused by a mutation of the <i>MEN1</i> gene encoding the tumor suppressor menin, mainly manifest prolactinomas and somatotropinomas and only about 5% of their totality is represented by corticotroph tumors<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. So far, a single case of CA has been described in MEN4, in which the cell cycle regulator p27<sup>Kip1</sup> is impaired by inactivating mutations of the <i>CDKN1B</i> gene<sup><a href="#ref-10">10</a></sup>. In CNC, caused by inactivating germline mutations of the <i>PRKAR1A</i> gene which encodes the type 1 regulatory subunit of protein kinase A, one case of CA has been reported<sup><a href="#ref-11">11</a></sup>. In DICER1 syndrome, which is associated with the development of different types of blastomas during embryogenesis, 2% of the affected patients develop corticotroph blastomas as the only pituitary blastoma manifestation<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. Patients with DICER1 syndrome bear an autosomal dominant mutation of the <i>DICER1</i> gene which encodes the DICER protein, a microRNA (miR) processing endoribonuclease. This suggests that a disturbed production of miRs and thus an altered regulation of their target mRNAs may be responsible for the development of the corticotroph blastomas. However, it is not yet known which miRs are affected and how they induce corticotroph tumor development or why only a small subset of affected patients develops corticotroph blastomas<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>.</p><p class="" id=d8163e281>Hereditary disorders, in which the patients manifest only pituitary tumors, are designated FIPAs. About 20% of all patients with FIPA bear mutations of the aryl hydrocarbon receptor-interacting protein (AIP), whereas in the majority of FIPAs, the underlying mutations are not known. CAs account for about 5% of all pituitary tumors in FIPAs<sup><a href="#ref-14">14</a></sup>.</p><p class="" id=d8163e288>In several studies with big cohorts of patients with sporadic pituitary adenoma, only three cases of pathogenetic AIP mutations and three cases of menin mutations have been found in sporadic corticotropinomas, suggesting that mutations of genes causing hereditary corticotroph tumors play only a minor role in sporadic CA development<sup><a href="#ref-4">4</a>,<a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8163e304>Genetic and epigenetic modifications in sporadic corticotroph adenomas</h2><p class="" id=d8163e307>Most of the CAs (&gt;95%) are sporadic tumors of monoclonal origin<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>. Loss of heterozygosity in combination with different mutations leading to loss of tumor suppressor genes or activation of oncogenes (or both) may play a role in the initiation of sporadic CAs<sup><a href="#ref-19">19</a></sup>.</p><p class="" id=d8163e321>Despite considerable progress during the last decade, sufficient knowledge about the genetic background of CAs is still missing. Important progress has been made with the recent detection of recurrent gain-of-function mutations in the gene encoding a protein called ubiquitin-specific protease 8 (USP8) in about 20% to 60% of CAs in adult patients<sup><a href="#ref-20">20</a><a href="#ref-22">22</a></sup>. As the mutation was not found in any other type of pituitary tumors, it is evident that the mutation is specific for CAs<sup><a href="#ref-23">23</a></sup>. USP8 is involved in the ubiquitination/deubiquitination process, which is a modality of post-translational protein modification<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>. In this complex process, specific proteins are ubiquitinated and then degraded by the lysosome or are rescued from degradation by deubiquitination. USP8 is an enzyme that mediates the deubiquitination of target proteins, and described mutations in CAs lead to an increased activity of the protein. CAs with mutated USP8 exhibit more stable or higher levels of proteins whose activities are regulated by ubiquitination/deubiquitination<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>.</p><p class="" id=d8163e349>Multiple proteins are known to be regulated at least in part by ubiquitination/deubiquitination, and in principal all USP8 regulated proteins, if expressed in CAs, could be affected by USP8 mutations<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>. In this context, two candidate proteins that might play a pathogenic role and be a pharmacological target in CAs with mutated USP8 have already been identified: the epidermal growth factor receptor (EGFR)<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup> and the somatostatin receptor type 5 (SSTR5)<sup><a href="#ref-26">26</a></sup>. The tyrosine kinase receptor EGFR is expressed in corticotroph cells and mediates the ACTH-stimulating effect of the epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-)<sup><a href="#ref-27">27</a><a href="#ref-29">29</a></sup>. In CAs with USP8 mutations and thus enhanced deubiquitination, EGFR is stabilized and its expression is increased. Therefore, the ACTH-stimulating activity of EGF/TGF- is elevated and may contribute to the excessive ACTH production. Indeed, comparative studies between CAs with and without mutated USP8 have already shown that the expression and activity of the EGFR are enhanced in CAs with USP8 mutations,<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup> although this could not be confirmed in another study<sup><a href="#ref-26">26</a></sup>. In the case of SSTR5, USP8 mutations would lead to an increased expression and activity of this receptor and suggest that CAs with mutated USP8 may respond better to the treatment with pasireotide, a somatostatin analogue that suppresses CA growth and ACTH secretion through SSTR5<sup><a href="#ref-26">26</a>,<a href="#ref-30">30</a></sup>. In addition, a Cushings diseaserelevant protein, whose expression or function or both are regulated at least in part by ubiquitination/deubiquitination (and thus may be affected by USP8 mutations), is the glucocorticoid receptor (GR)<sup><a href="#ref-31">31</a></sup>. The latter regulates the responsiveness to glucocorticoids, resistance to which is a typical feature of Cushings disease. Whether a reduced sensitivity to glucocorticoids by CAs is related to the mutational status of USP8 still needs to be clarified. Interestingly, a recent article has shown evidence that in normal rat corticotroph cells the proopiomelanocortin (POMC) peptide is directly degraded by ubiquitination and therefore that the treatment of rat corticotropes with the polyubiquitination inhibitor K48R enhanced ACTH production<sup><a href="#ref-32">32</a></sup>. Whether this is also relevant in human corticotroph tumor cells has yet to be proven. Comparative investigations have demonstrated that CAs with mutated USP8 are smaller and that the prevalence for USP8 mutations is higher in women<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a>,<a href="#ref-33">33</a></sup>. In a recent study, a lower incidence of USP8 mutations was found in children with Cushings disease compared with adults<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. Whereas the prevalence of USP8 mutations was reduced in Crookes cell adenomas<sup><a href="#ref-26">26</a></sup>, the proportion of mutant USP8 in so-called Nelsons tumors (see the Corticotroph pituitary tumor types section) was identical to that in corticotropinomas in general<sup><a href="#ref-35">35</a></sup>. Patients with USP8 mutations were diagnosed significantly earlier and had higher preoperative 24-hour urinary-free cortisol levels<sup><a href="#ref-36">36</a></sup>. After surgery, recurrences were more abundant and appeared significantly earlier in patients with USP8 mutant corticotropinomas<sup><a href="#ref-36">36</a></sup>. In contrast to ACTH-secreting CAs, no USP8 mutations have been detected in a small number (n = 13) of silent CAs studied<sup><a href="#ref-33">33</a></sup> but this has to be confirmed in a bigger cohort of this tumor type. Interestingly, no mutant USP8 has been found in tumors from a big cohort of dogs with Cushings disease, suggesting that the mutation is primate-specific<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d8163e446>So far, apart from mutated USP8, no other recurrent mutations have been found in CAs<sup><a href="#ref-4">4</a>,<a href="#ref-23">23</a>,<a href="#ref-38">38</a></sup>. Thus, more than half of the CA cases may have a variable genetic background and may be associated with mutations of different single genes or may be caused by epigenetic mechanisms (see below). So far, several mutations of different genes have been described in CAs, which mainly affected cell cycleregulating proteins, signal transduction proteins, oncogenes, and tumor suppressors<sup><a href="#ref-4">4</a>,<a href="#ref-23">23</a>,<a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. Very recently, loss-of-function mutations of the Cdk5 and ABL enzyme substrate 1 (<i>CABLES1</i>) gene were found in four patients from a cohort of 146 pediatric and 35 adult patients with Cushings disease: two in children and two in young adults<sup><a href="#ref-40">40</a></sup>. The mutated CABLES1 protein lost its inhibitory action on corticotropinoma cell growth, which may explain why all affected patients had corticotroph macroadenomas<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d8163e484>Given that mutations play a tumorigenic role in only a part of the corticotropinomas, it is thought that epigenetic changes such as DNA methylation, histone methylation/acetylation, and miR are of considerable impact for corticotropinoma formation<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. Most studies on this subject have been performed in unselected cohorts of different types of pituitary adenomas; among them, corticotropinomas and epigenetic changes of different factors have been detected in subsets of the adenomas. Corticotropinoma-specific studies on histone deacetylases have demonstrated that a loss of HDAC2 might play a role in inducing glucocorticoid resistance<sup><a href="#ref-43">43</a></sup>, and treatment with histone deacetylase inhibitors reduced survival and ACTH secretion in corticotroph tumor cells<sup><a href="#ref-44">44</a></sup>. Many of the epigenetic changes caused by DNA methylation or histone methylation/acetylation have direct or indirect effects on the expression of the tumor suppressors p53 and retinoblastoma (Rb) protein, suggesting that these factors are prominent targets of epigenetic changes<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. A case report of loss of Rb expression in a corticotroph carcinoma<sup><a href="#ref-45">45</a></sup> supports the concept that this tumor suppressor plays a role in corticotropinoma development but apparently it is involved in tumor progression rather than in adenoma initiation.</p><p class="" id=d8163e513>In regard to miRs, which bind to specific messenger RNAs and block their translation into corresponding proteins, several entities have been reported to be either over- or under-expressed in pituitary adenomas in general<sup><a href="#ref-46">46</a><a href="#ref-48">48</a></sup> or specifically in CAs<sup><a href="#ref-49">49</a><a href="#ref-51">51</a></sup>. For instance, invasive characteristics of pituitary tumors were found to be associated with the over-expression of the miR-106b~25 cluster consisting of miR-25, miR-93, and miR-106b<sup><a href="#ref-50">50</a></sup>. Moreover, aggressive corticotroph Crookes cell adenomas had a higher expression of miR-106b~25 than other corticotropinomas, suggesting that this miR cluster is also associated with corticotroph tumor aggressiveness<sup><a href="#ref-50">50</a></sup>. In another study about miR expression specifically in corticotropinomas, patients presenting reduced miR-141 levels showed a better chance of remission, whereas the reduced expression of other miRs (miR-15a, miR-16, miR-21, miR-141, miR-143, miR-145, miR-150, and let-7a) had no association with corticotropinoma phenotype or clinical parameters of the affected patients<sup><a href="#ref-49">49</a></sup>. The targets and pathological consequences of miRs in CAs have been identified in only a few cases<sup><a href="#ref-48">48</a>,<a href="#ref-51">51</a></sup>, and much more work has to be done to identify the pathological mechanisms of aberrant miR expression.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8163e553>Glucocorticoid resistance in corticotroph adenomas</h2><p class="" id=d8163e556>In normal corticotroph cells, ACTH production and release are under negative feedback control of glucocorticoids and are well balanced. If needed, the ACTH and thus glucocorticoid production can be transiently adapted to specific physiological or pathophysiological conditions (stress, infections, inflammation, and so on)<sup><a href="#ref-52">52</a></sup>. Corticotroph tumor cells produce excessive amounts of ACTH despite strongly elevated glucocorticoid serum levels, indicating that the negative glucocorticoid feedback is impaired. It is still not clear why corticotroph tumor cells are resistant to glucocorticoids. Inactivating mutations of the GR encoding nuclear receptor subfamily 3 group C member 1 (<i>NR3C1</i>) gene are rare, and as corticotroph tumor cells show mostly enhanced GR levels, the missing response to glucocorticoids cannot be explained by GR downregulation<sup><a href="#ref-23">23</a>,<a href="#ref-39">39</a>,<a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. Thus, an alternate impairment of the function of GR must be responsible for the glucocorticoid resistance, and two candidatesthe testicular orphan nuclear receptor 4 (TR4) and heat shock protein 90 (HSP90)are discussed to play important roles in GR dysfunction.</p><p class="" id=d8163e579>TR4 is a nuclear receptor which can both activate and repress transcription in different types of organs. TR4 is overexpressed in CAs and corticotroph tumor cell lines and is able to activate the ACTH encoding <i>POMC</i> gene by binding to its promoter<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>. The activation is further enhanced if TR4 is phosphorylated through the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway. In nude mice harboring corticotroph tumors, TR4 overexpression stimulated ACTH secretion and tumor cell growth<sup><a href="#ref-55">55</a></sup>. It was shown that TR4 interacts with the GR and could overcome the negative regulation of GR on <i>POMC</i> transcription and ACTH secretion, suggesting that TR4 might promote resistance to negative glucocorticoid feedback<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>. Suppression of ERK-mediated TR4 phosphorylation by the ERK inhibitor MEK-162 in a murine model of corticotroph tumors reduced ACTH production and inhibited tumor growth, indicating that targeting TR4 action or suppression (or both) could be a novel therapy for Cushings disease<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d8163e611>HSP90 is a chaperone protein that stabilizes and regulates different proteins by inducing conformational changes. HSP90 interferes with the GR to facilitate ligand binding and receptor translocation to the nucleus and therefore plays an important role in the function of the GR<sup><a href="#ref-58">58</a></sup>. However, under certain conditions, HSP90 can impair GR function<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. HSP90 expression is strongly enhanced in the anterior pituitary in patients with CA in comparison with the normal anterior pituitary, and it was shown that HSP90 overexpression restrains the release of mature GR from the chaperone, leading to partial glucocorticoid resistance<sup><a href="#ref-61">61</a></sup>. C-terminal inhibitors of HSP90 such as novobiocin and the herbal compound silibinin could induce the release of mature GR in corticotroph tumor cells <i>in vitro</i>, and <i>in vivo</i> silibinin was able to revert glucocorticoid resistance in a corticotroph tumor allograft mouse model, leading to a partial restoration of symptoms of the disease<sup><a href="#ref-61">61</a></sup>. This suggests that silibinin, a safe drug already used in humans for the treatment of liver disease and amanitin intoxication<sup><a href="#ref-62">62</a></sup>, may represent a novel therapeutic option for the treatment of Cushings disease and corresponding clinical studies are currently in preparation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8163e647>Progression of corticotroph adenomas</h2><div class=section><a name=d8163e650 class=n-a></a><h3 class=section-title>Corticotroph pituitary tumor types</h3><p class="" id=d8163e655>According to the 2017 World Health Organization (WHO) classification of pituitary tumors, CAs are characterized by the expression of Tpit, a transcription factor specifically expressed in the ACTH-producing pituitary cell lineage. Histologically, hormone-secreting CAs are further subclassified into densely and sparsely granulated CAs and Crookes cell adenomas<sup><a href="#ref-2">2</a></sup>. Not classified as a specific entity in the 2017 WHO classification are Nelsons tumors, the original designation of aggressively progressing corticotroph macroadenomas developing in 8% to 29% of patients, in which the chronic hypercortisolism had been treated by bilateral adrenalectomy<sup><a href="#ref-63">63</a><a href="#ref-65">65</a></sup>. It was thought that the removal of cortisol excess could play a causative role in the development of Nelsons tumors. However, as CAs in adrenalectomized patients mostly remain stable or progress slowly and as the patients receive adequate cortisol replacement therapy, it is unlikely that the adrenalectomy-associated removal of excessive cortisol alone is responsible for the formation of Nelsons tumors<sup><a href="#ref-63">63</a><a href="#ref-65">65</a></sup>. Nevertheless, owing to elevated proliferative index and enhanced invasive growth, Nelsons tumors can evolve to carcinomas in rare cases<sup><a href="#ref-66">66</a></sup>. There is no evidence for a common specific genetic background leading to the formation of Nelsons tumors, and in a recent study the proportion of USP8 mutations (45%) was found to be similar to that of corticotroph tumors in general<sup><a href="#ref-35">35</a></sup>. Thus, the mechanisms triggering the development of Nelsons tumors are still unknown<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup>.</p><p class="" id=d8163e692>Crookes cell adenomas are characterized by the replacement of cytoplasmic granules by hyaline material<sup><a href="#ref-2">2</a></sup>, a process that has been designated Crookes change. In a recent study, it was shown that depending on the degree of hypercortisolism, densely/sparsely corticotroph tumors show focal Crookes changes<sup><a href="#ref-67">67</a></sup>. This suggests that Crookes cell adenomas have no specific genetic/epigenetic background but derive from densely/sparsely CAs at a high hypercortisolemic state. This is supported by the observation that there is little difference in the proportion of USP8-mutated and non-mutated tumors between densely/sparsely granulated CAs and Crookes cell adenomas<sup><a href="#ref-26">26</a></sup>. At present, the underlying mechanisms triggering the development of Crookes cell adenomas are not known. In the 2017 WHO high-risk pituitary adenoma subclassification, Crookes cell adenomas are listed as an aggressive tumor type as these tumors have an elevated proliferative index and are already invasively growing at a microadenoma state<sup><a href="#ref-2">2</a></sup>. As Crookes cell adenomas are at risk to transform to corticotroph carcinomas, chemotherapeutic treatment of these adenomas is recommended to prevent the transformation<sup><a href="#ref-68">68</a></sup>. Silent CAs also belong to the aggressive pituitary tumor types in the new WHO classification. This tumor entity is immunopositive for Tpit and expresses different POMC precursor proteins but does not secrete ACTH; moreover, genes related to ACTH synthesis are differently expressed in comparison with ACTH-secreting CAs<sup><a href="#ref-2">2</a>,<a href="#ref-69">69</a></sup>. Thus, silent CAs clinically represent a member of the group of non-functioning pituitary adenomas (NFPAs), and according to recent studies, up to 20% of all NFPAs are silent CAs<sup><a href="#ref-5">5</a></sup>. There are several hypotheses and speculations about silent CAs and their inability to secrete ACTH. Silent CAs may not derive from normal anterior pituitary corticotroph cells but may originate from POMC-expressing cells of the pars intermedia and thus may have characteristics different from those of normal CAs<sup><a href="#ref-69">69</a></sup>. There is also electron microscopebased evidence that silent CAs have elevated lysosome numbers and show fusions of these lysosomes with secretory granules and this has led to speculation that ACTH is intracellularly destroyed before it can be secreted<sup><a href="#ref-70">70</a></sup>. Alternatively, the function or expression of POMC productprocessing enzymes may be disturbed in silent CAs and indeed abnormalities of these prohormone convertases have been described<sup><a href="#ref-71">71</a></sup>. However, the processes responsible for silent CA development still need to be clarified in future studies. The observation that silent corticotropinomas probably have no mutated USP8 may indicate that silent CAs have a different genetic background compared with classic CAs<sup><a href="#ref-33">33</a></sup>. However, in some cases, silent CAs have spontaneously changed to secretory CAs and vice versa, suggesting that at least in some cases silent and secretory CAs may have the same origin<sup><a href="#ref-72">72</a></sup>. Like most NFPAs, silent CAs are diagnosed quite late when they have already formed invasively growing macroadenomas. At this state, complete surgical resection is not possible and further clinical management of these tumors is quite challenging; in rare cases, silent CAs finally transform to carcinomas<sup><a href="#ref-73">73</a>,<a href="#ref-74">74</a></sup>.</p></div><div class=section><a name=d8163e756 class=n-a></a><h3 class=section-title>Microadenomas, macroadenomas, and aggressive corticotroph tumors</h3><p class="" id=d8163e761>At diagnosis, most of the ACTH-secreting CAs are microadenomas and in some cases are hardly visible by routine imaging techniques<sup><a href="#ref-1">1</a></sup>. When CAs have reached a critical size of more than 2 mm in diameter, oxygen transport to the tumor cells per diffusion will no longer be sufficient and will lead to tumor neovascularization through angiogenesis forced by intratumoral hypoxia<sup><a href="#ref-75">75</a>,<a href="#ref-76">76</a></sup>. The most important regulator of angiogenesis is the hypoxia-inducible factor-1 (HIF-1), which is inactive under normoxic conditions but active under hypoxia<sup><a href="#ref-77">77</a></sup>. Activated HIF-1 induces the production of multiple angiogenic factorsfor example, vascular endothelial growth factor-A (VEGF-A), basic fibroblast growth factor, and platelet-derived growth factorand suppresses the formation of anti-angiogenic components. This finally stimulates the proliferation of endothelial cells and pericytes, promotes the formation of tubular structures, and induces the targeted sprouting of the newly formed vessels into the hypoxic zones of the growing tumor<sup><a href="#ref-77">77</a></sup>. HIF-1 is a heterodimeric protein composed of two subunits: oxygen-regulated HIF-1 and constitutively expressed HIF-1<sup><a href="#ref-78">78</a></sup>. Under normoxic conditions, HIF-1 has a very short half-life due to permanent degradation by ubiquitination and therefore little or no active HIF-1 is present. During hypoxia, the ubiquitination of HIF-1 is blocked and active HIF-1 is formed to induce the angiogenic processes<sup><a href="#ref-78">78</a></sup>. As the previously mentioned USP8 protein interferes with HIF-1 deubiquitination processes<sup><a href="#ref-25">25</a>,<a href="#ref-79">79</a></sup>, it would be interesting to study whether HIF-1 levels are different in corticotropinomas with and without mutated USP8 and whether corticotropinoma vascularization might be affected as in the case of the product of the <i>RWWD3</i> gene, RWD-domain-containing sumoylation enhancer (RSUME)<sup><a href="#ref-80">80</a></sup>. The latter is upregulated under hypoxia and overexpressed in pituitary tumors, including corticotropinomas<sup><a href="#ref-81">81</a></sup>. It has been shown that RSUME could stabilize HIF-1 and thus enhance VEGF-A secretion. Therefore, the knock-down of RSUME was associated with reduced production of HIF-1 and VEGF-A in pituitary tumors <i>in vitro</i> and <i>in vivo</i><sup><a href="#ref-81">81</a></sup>. Whether USP8 has similar HIF-1stabilizing properties and thus influences angiogenic growth factor production in corticotroph tumors needs to be clarified.</p><p class="" id=d8163e820>The intratumoral formation of new vessels requires the disruption of cellcell contacts between tumor cells. Thus, during neovascularization, not only factors stimulating the growth of vessels but also factors degrading the extracellular matrix of tumor cells are produced<sup><a href="#ref-76">76</a></sup>. In these processes, enzymes of the matrix metalloproteinase (MMP) family and their negative regulators, the tissue inhibitors of MMPs (TIMPs), play important roles<sup><a href="#ref-82">82</a>,<a href="#ref-83">83</a></sup>, but numerous other factors are also involved<sup><a href="#ref-76">76</a></sup>. These soluble factors not only may locally act to pave the way for invading vessels but may diffuse into the tumor cell matrix and into the anatomical structures surrounding the adenomas. Therefore, the process of neovascularization bears the risk that matrix degrading components support the migration of tumor cells to invade surrounding tissues at the edge of the tumors<sup><a href="#ref-84">84</a>,<a href="#ref-85">85</a></sup>. The link between angiogenesis and invasiveness is supported by the observation that RSUME not only has angiogenic properties in corticotroph tumors but also stimulates migration and invasive growth of corticotroph tumor cells<sup><a href="#ref-86">86</a></sup>. Normally, corticotroph macroadenomas show invasive growth characteristics, but in Crookes cell adenomas, for instance, invasive growth has already been observed in microadenomas<sup><a href="#ref-2">2</a></sup>.</p><p class="" id=d8163e854>Comparative studies between the normal anterior pituitary and CAs have identified hundreds of genes, miRs, proteins, and peptides that are up- or down-regulated in the adenomas<sup><a href="#ref-87">87</a></sup>. This is not surprising as, in the adult anterior pituitary, cells normally do not grow and neither angiogenic nor invasive processes take place. Thus, all factors related to these events are somehow differentially expressed in the corticotropinomas, but it should be emphasized that these aberrant expression patterns are mainly a consequence, not a cause, of CAs. Correspondingly, there are also differences between non-invasive and invasive growing corticotroph tumors<sup><a href="#ref-88">88</a>,<a href="#ref-89">89</a></sup>, such as differential expression of the miR106b~25 cluster, the cyclin D2 (<i>CCND2</i>), zinc finger protein 676 (<i>ZNF676</i>), death-associated protein kinase 1 (<i>DAPK1</i>), and <i>TIMP2</i> genes as well as genes associated with TGF- and G protein signaling pathways, DNA damage response pathways, focal adhesionassociated pathways, and others<sup><a href="#ref-48">48</a>,<a href="#ref-50">50</a>,<a href="#ref-88">88</a><a href="#ref-92">92</a></sup>. Although it has been speculated that all of the aberrantly expressed factors play a role in corticotropinoma expansion and thus represent putative targets for pharmacological treatment, this has been proven <i>in vivo</i> in mouse allograft corticotroph tumor models in only a few cases but has not led to corresponding clinical studies.</p></div><div class=section><a name=d8163e898 class=n-a></a><h3 class=section-title>Corticotroph carcinomas</h3><p class="" id=d8163e903>According to the 2017 WHO classification, pituitary carcinomas, which represent less than 0.1% of all pituitary tumors, are characterized by their ability to form metastases and both hereditary and sporadic pituitary tumors can transform into carcinomas<sup><a href="#ref-2">2</a></sup>. Although the proportion of CAs within all pituitary tumor types is relatively small, they represent about 35% to 48% of all pituitary carcinomas<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a>,<a href="#ref-93">93</a></sup>. This may be a consequence of the relative high proportion of aggressive tumor types (Crookes cell adenomas, Nelsons tumors, and silent CAs) among the corticotroph tumors<sup><a href="#ref-2">2</a></sup>. In most reports, several common features of corticotroph carcinomas are evident, such as repeated recurrence of the adenomas after incomplete surgical resection and transient response but finally resistance to different pharmacological therapies or to radiotherapy<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a>,<a href="#ref-66">66</a>,<a href="#ref-68">68</a>,<a href="#ref-73">73</a>,<a href="#ref-74">74</a>,<a href="#ref-94">94</a></sup>. Usually, decades separate the first diagnosis of the CA and the full expression of the carcinoma phenotype. At present, there is no evidence of a specific genetic or epigenetic background or a common factor that is responsible for the development of pituitary carcinomas<sup><a href="#ref-95">95</a></sup>. In a recent meta-analysis, in which pituitary carcinomas were compared with aggressive adenomas, a number of factors related to the stimulation of cell growth, angiogenesis, and invasiveness (cyclin D1, VEGF, MMP9, miR-122, and miR-493) were found to be up-regulated, whereas several factors, including growth inhibitors and apoptosis inducers (p16Ink4A, p27Kip1, MT3, BCL-2, Bax, Bcl-X, and O<sup>6</sup>-methylguanine DNA methyltransferase [MGMT]), were down-regulated<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>. However, these factors are also differently expressed in invasive versus non-invasive adenomas, in micro- versus macro-adenomas, or in poorly versus densely vascularised pituitary tumors<sup><a href="#ref-76">76</a>,<a href="#ref-84">84</a>,<a href="#ref-87">87</a></sup>. These data suggest that an accumulation of changes associated with increased pituitary tumor aggressiveness rather than a carcinoma-specific mutation or epigenetic change (or both) will finally lead to development of metastasizing pituitary carcinomas<sup><a href="#ref-93">93</a>,<a href="#ref-95">95</a></sup>.</p><p class="" id=d8163e979>Temozolomide, an alkylating chemotherapeutic drug, has been identified as an effective compound in the treatment of pituitary carcinomas<sup><a href="#ref-7">7</a>,<a href="#ref-94">94</a></sup>. The effect of temozolomide is reduced in pituitary tumors with high expression of MGMT. Crookes cell adenomas, Nelsons tumors, invasively growing corticotroph macroadenomas, and corticotroph carcinomas mostly have low MGMT expression<sup><a href="#ref-2">2</a>,<a href="#ref-97">97</a><a href="#ref-100">100</a></sup>. This may explain the relatively good response of corticotroph carcinomas to temozolomide therapy in several cases<sup><a href="#ref-7">7</a>,<a href="#ref-94">94</a></sup>. However, this also suggests that advanced aggressive corticotropinoma types may already be treated with temozolomide to prevent transformation into corticotroph carcinomas<sup><a href="#ref-101">101</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8163e1015>Conclusions</h2><p class="" id=d8163e1018>CAs are mostly sporadic tumors; only a small proportion of CAs have a hereditary background and are associated with neuroendocrine syndromes or are FIPAs. In sporadic CAs, a recurrent activating mutation of the <i>USP8</i> gene, which is present in about 40% of ACTH-secreting CAs, has recently been found. The USP8 mutation participates in CA pathophysiology by stimulating EGFR expression and thus enhances EGF-induced ACTH production. As mutated USP8 also increases SSTR5 expression, CAs with USP8 mutation respond better to treatment with the somatostatin analogue pasireotide which acts through SSTR5. No other recurrent mutations have been identified in CAs, suggesting that single different mutations or epigenetic changes (or both) may play a role in CA initiation. The ACTH secretion by corticotroph tumor cells, in contrast to normal corticotroph cells, is resistant to inhibitory glucocorticoid feedback control, and HSP90 overexpression has recently been shown to be involved in Cushings disease. Thus, HSP90 inhibitors like silibinin may be promising drugs to restore glucocorticoid responsiveness of CAs and to reverse the pathophysiological changes of Cushings disease. During the progression of CAs from microadenomas to aggressive macroadenomas and finally rare cases of corticotroph carcinomas, multiple factors (genes, miRs, proteins, and peptides) are up- or down-regulated and thus may provide putative targets for new pharmacological treatment strategies. However, despite remarkable progress in understanding corticotroph tumor initiation and progression, a lot of work is still needed to explore the underlying mechanisms, and the translation of new findings into clinical applications for diagnosis and therapy of corticotropinomas is still unsatisfactory.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8163e1027>Abbreviations</h2><p class="" id=d8163e1030>ACTH, adrenocorticotropic hormone; AIP, aryl hydrocarbon receptor-interacting protein; CA, corticotroph adenoma; CABLES1, Cdk5 and ABL enzyme substrate 1; CNC, Carney complex; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase; FIPA, familial isolated pituitary adenomas; GR, glucocorticoid receptor; HIF-1, hypoxia-inducible factor 1; HSP90, heat shock protein 90; MAPK, mitogen-activated protein kinase; MEN, multiple endocrine neoplasia; MGMT, O<sup>6</sup>-methylguanine DNA methyltransferase; miR, microRNA; MMP, matrix metalloproteinase; NFPA, non-functioning pituitary adenoma; POMC, proopiomelanocortin; Rb, retinoblastoma; RSUME, RWD-domain-containing sumoylation enhancer; SSTR5, somatostatin receptor type 5; TGF, transforming growth factor; TIMP, tissue inhibitor of metalloproteinase; TR4, testicular orphan nuclear receptor 4; USP8, ubiquitin-specific protease 8; VEGF-A, vascular endothelial growth factor-A; WHO, World Health Organization.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d8163e1 class=n-a></a><h2 class=main-title id=d8476>Grant information</h2><p>This work was funded by a grant from the German Research Council (DFG) to GKS (STA 285/20-1).</p><p><i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i></p></div><div class=back-section><a name=d8163e1040 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d8816>References</h2><div class="section ref-list"><a name=d8163e1040 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d8163e1047 class=n-a></a>Pivonello R, De Leo M, Cozzolino A, <i> et al.</i>: The Treatment of Cushing's Disease. <i>Endocr Rev.</i> 2015; <b>36</b>(4): 385486. <a target=xrefwindow id=d8163e1058 href="http://www.ncbi.nlm.nih.gov/pubmed/26067718">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1061 href="http://dx.doi.org/10.1210/er.2013-1048">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1065 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4523083">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d8163e1074 class=n-a></a>Mete O, Lopes MB: Overview of the 2017 WHO Classification of Pituitary Tumors. <i>Endocr Pathol.</i> 2017; <b>28</b>(3): 22843. <a target=xrefwindow id=d8163e1082 href="http://www.ncbi.nlm.nih.gov/pubmed/28766057">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1085 href="http://dx.doi.org/10.1007/s12022-017-9498-z">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d8163e1094 class=n-a></a>Lodish M: Cushing's syndrome in childhood: update on genetics, treatment, and outcomes. <i>Curr Opin Endocrinol Diabetes Obes.</i> 2015; <b>22</b>(1): 4854. <a target=xrefwindow id=d8163e1102 href="http://www.ncbi.nlm.nih.gov/pubmed/25517021">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1105 href="http://dx.doi.org/10.1097/MED.0000000000000127">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1108 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4415092">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d8163e1117 class=n-a></a>Xiong Q, Ge W: Gene mutations in Cushing's disease. <i>Biomed Rep.</i> 2016; <b>5</b>(3): 27782. <a target=xrefwindow id=d8163e1125 href="http://www.ncbi.nlm.nih.gov/pubmed/27588171">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1128 href="http://dx.doi.org/10.3892/br.2016.729">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1131 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4998087">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d8163e1140 class=n-a></a>Ben-Shlomo A, Cooper O: Silent corticotroph adenomas. <i>Pituitary.</i> 2018; <b>21</b>(2): 18393. <a target=xrefwindow id=d8163e1148 href="http://www.ncbi.nlm.nih.gov/pubmed/29344907">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1151 href="http://dx.doi.org/10.1007/s11102-018-0864-8">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d8163e1161 class=n-a></a>Yoo F, Kuan EC, Heaney AP, <i> et al.</i>: Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review. <i>Pituitary.</i> 2018; <b>21</b>(3): 290301. <a target=xrefwindow id=d8163e1172 href="http://www.ncbi.nlm.nih.gov/pubmed/29404894">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1175 href="http://dx.doi.org/10.1007/s11102-018-0872-8">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732455876"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1184 class=n-a></a>McCormack A, Dekkers OM, Petersenn S, <i> et al.</i>: Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. <i>Eur J Endocrinol.</i> 2018; <b>178</b>(3): 26576. <a target=xrefwindow id=d8163e1195 href="http://www.ncbi.nlm.nih.gov/pubmed/29330228">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1198 href="http://dx.doi.org/10.1530/EJE-17-0933">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732455876">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d8163e1211 class=n-a></a>Schernthaner-Reiter MH, Trivellin G, Stratakis CA: MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics. <i>Neuroendocrinology.</i> 2016; <b>103</b>(1): 1831. <a target=xrefwindow id=d8163e1219 href="http://www.ncbi.nlm.nih.gov/pubmed/25592387">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1222 href="http://dx.doi.org/10.1159/000371819">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1225 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4497946">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d8163e1234 class=n-a></a>Vannucci L, Marini F, Giusti F, <i> et al.</i>: MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors. <i>Endocrine.</i> 2018; <b>59</b>(2): 43848. <a target=xrefwindow id=d8163e1245 href="http://www.ncbi.nlm.nih.gov/pubmed/28530019">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1248 href="http://dx.doi.org/10.1007/s12020-017-1322-5">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d8163e1257 class=n-a></a>Georgitsi M, Raitila A, Karhu A, <i> et al.</i>: Germline <i>CDKN1B</i>/p27<sup>Kip1</sup> mutation in multiple endocrine neoplasia. <i>J Clin Endocrinol Metab.</i> 2007; <b>92</b>(8): 33215. <a target=xrefwindow id=d8163e1275 href="http://www.ncbi.nlm.nih.gov/pubmed/17519308">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1278 href="http://dx.doi.org/10.1210/jc.2006-2843">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d8163e1287 class=n-a></a>Kiefer FW, Winhofer Y, Iacovazzo D, <i> et al.</i>: <i>PRKAR1A</i> mutation causing pituitary-dependent Cushing disease in a patient with Carney complex. <i>Eur J Endocrinol.</i> 2017; <b>177</b>(2): K7K12. <a target=xrefwindow id=d8163e1301 href="http://www.ncbi.nlm.nih.gov/pubmed/28522647">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1305 href="http://dx.doi.org/10.1530/EJE-17-0227">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d8163e1315 class=n-a></a>de Kock L, Sabbaghian N, Plourde F, <i> et al.</i>: Pituitary blastoma: a pathognomonic feature of germ-line <i>DICER1</i> mutations. <i>Acta Neuropathol.</i> 2014; <b>128</b>(1): 11122. <a target=xrefwindow id=d8163e1329 href="http://www.ncbi.nlm.nih.gov/pubmed/24839956">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1333 href="http://dx.doi.org/10.1007/s00401-014-1285-z">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1336 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4129448">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d8163e1345 class=n-a></a>Sahakitrungruang T, Srichomthong C, Pornkunwilai S, <i> et al.</i>: Germline and somatic <i>DICER1</i> mutations in a pituitary blastoma causing infantile-onset Cushing's disease. <i>J Clin Endocrinol Metab.</i> 2014; <b>99</b>(8): E148792. <a target=xrefwindow id=d8163e1359 href="http://www.ncbi.nlm.nih.gov/pubmed/24823459">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1363 href="http://dx.doi.org/10.1210/jc.2014-1016">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d8163e1372 class=n-a></a>Hernndez-Ramrez LC, Gabrovska P, Dnes J, <i> et al.</i>: Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in <i>AIP</i> Mutation Carriers. <i>J Clin Endocrinol Metab.</i> 2015; <b>100</b>(9): E124254. <a target=xrefwindow id=d8163e1386 href="http://www.ncbi.nlm.nih.gov/pubmed/26186299">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1390 href="http://dx.doi.org/10.1210/jc.2015-1869">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1393 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4570169">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d8163e1402 class=n-a></a>Lecoq AL, Bouligand J, Hage M, <i> et al.</i>: Very low frequency of germline <i>GPR101</i> genetic variation and no biallelic defects with <i>AIP</i> in a large cohort of patients with sporadic pituitary adenomas. <i>Eur J Endocrinol.</i> 2016; <b>174</b>(4): 52330. <a target=xrefwindow id=d8163e1420 href="http://www.ncbi.nlm.nih.gov/pubmed/26792934">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1423 href="http://dx.doi.org/10.1530/EJE-15-1044">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d8163e1432 class=n-a></a>Cazabat L, Bouligand J, Salenave S, <i> et al.</i>: Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. <i>J Clin Endocrinol Metab.</i> 2012; <b>97</b>(4): E66370. <a target=xrefwindow id=d8163e1443 href="http://www.ncbi.nlm.nih.gov/pubmed/22319033">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1446 href="http://dx.doi.org/10.1210/jc.2011-2291">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d8163e1455 class=n-a></a>Herman V, Fagin J, Gonsky R, <i> et al.</i>: Clonal origin of pituitary adenomas. <i>J Clin Endocrinol Metab.</i> 1990; <b>71</b>(6): 142733. <a target=xrefwindow id=d8163e1466 href="http://www.ncbi.nlm.nih.gov/pubmed/1977759">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1469 href="http://dx.doi.org/10.1210/jcem-71-6-1427">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d8163e1479 class=n-a></a>Gicquel C, Le Bouc Y, Luton JP, <i> et al.</i>: Monoclonality of corticotroph macroadenomas in Cushing's disease. <i>J Clin Endocrinol Metab.</i> 1992; <b>75</b>(2): 4725. <a target=xrefwindow id=d8163e1490 href="http://www.ncbi.nlm.nih.gov/pubmed/1322426">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1493 href="http://dx.doi.org/10.1210/jcem.75.2.1322426">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d8163e1502 class=n-a></a>Biller BM, Alexander JM, Zervas NT, <i> et al.</i>: Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. <i>J Clin Endocrinol Metab.</i> 1992; <b>75</b>(5): 13039. <a target=xrefwindow id=d8163e1513 href="http://www.ncbi.nlm.nih.gov/pubmed/1358909">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1516 href="http://dx.doi.org/10.1210/jcem.75.5.1358909">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725267788"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1525 class=n-a></a>Reincke M, Sbiera S, Hayakawa A, <i> et al.</i>: Mutations in the deubiquitinase gene <i>USP8</i> cause Cushing's disease. <i>Nat Genet.</i> 2015; <b>47</b>(1): 318. <a target=xrefwindow id=d8163e1539 href="http://www.ncbi.nlm.nih.gov/pubmed/25485838">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1543 href="http://dx.doi.org/10.1038/ng.3166">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725267788">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725355022"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1556 class=n-a></a>Ma ZY, Song ZJ, Chen JH, <i> et al.</i>: Recurrent gain-of-function <i>USP8</i> mutations in Cushing's disease. <i>Cell Res.</i> 2015; <b>25</b>(3): 30617. <a target=xrefwindow id=d8163e1570 href="http://www.ncbi.nlm.nih.gov/pubmed/25675982">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1574 href="http://dx.doi.org/10.1038/cr.2015.20">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1577 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4349249">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725355022">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733389597"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1590 class=n-a></a>Ballmann C, Thiel A, Korah HE, <i> et al.</i>: <i>USP8</i> Mutations in Pituitary Cushing Adenomas-Targeted Analysis by Next-Generation Sequencing. <i>J Endocr Soc.</i> 2018; <b>2</b>(3): 26678. <a target=xrefwindow id=d8163e1604 href="http://www.ncbi.nlm.nih.gov/pubmed/29600293">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1608 href="http://dx.doi.org/10.1210/js.2017-00364">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1611 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5838826">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733389597">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726782621"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1624 class=n-a></a>Song ZJ, Reitman ZJ, Ma ZY, <i> et al.</i>: The genome-wide mutational landscape of pituitary adenomas. <i>Cell Res.</i> 2016; <b>26</b>(11): 12559. <a target=xrefwindow id=d8163e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/27670697">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1638 href="http://dx.doi.org/10.1038/cr.2016.114">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1642 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5099864">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726782621">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d8163e1656 class=n-a></a>He M, Zhou Z, Shah AA, <i> et al.</i>: The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics. <i>Cell Biosci.</i> 2016; <b>6</b>: 62. <a target=xrefwindow id=d8163e1667 href="http://www.ncbi.nlm.nih.gov/pubmed/28031783">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1670 href="http://dx.doi.org/10.1186/s13578-016-0127-1">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1674 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5168870">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d8163e1683 class=n-a></a>Lei H, Shan H, Wu Y: Targeting deubiquitinating enzymes in cancer stem cells. <i>Cancer Cell Int.</i> 2017; <b>17</b>: 101. <a target=xrefwindow id=d8163e1691 href="http://www.ncbi.nlm.nih.gov/pubmed/29142505">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1694 href="http://dx.doi.org/10.1186/s12935-017-0472-0">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1697 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5670729">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725944519"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1706 class=n-a></a>Hayashi K, Inoshita N, Kawaguchi K, <i> et al.</i>: The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease. <i>Eur J Endocrinol.</i> 2016; <b>174</b>(2): 21326. <a target=xrefwindow id=d8163e1717 href="http://www.ncbi.nlm.nih.gov/pubmed/26578638">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1720 href="http://dx.doi.org/10.1530/EJE-15-0689">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725944519">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d8163e1733 class=n-a></a>Renner U, Paez-Pereda M, Arzt E, <i> et al.</i>: Growth factors and cytokines: function and molecular regulation in pituitary adenomas. <i>Front Horm Res.</i> 2004; <b>32</b>: 96109. <a target=xrefwindow id=d8163e1744 href="http://www.ncbi.nlm.nih.gov/pubmed/15281341">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1747 href="http://dx.doi.org/10.1159/000079039">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d8163e1756 class=n-a></a>Theodoropoulou M, Arzberger T, Gruebler Y, <i> et al.</i>: Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. <i>J Endocrinol.</i> 2004; <b>183</b>(2): 38594. <a target=xrefwindow id=d8163e1767 href="http://www.ncbi.nlm.nih.gov/pubmed/15531726">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1770 href="http://dx.doi.org/10.1677/joe.1.05616">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d8163e1779 class=n-a></a>Cooper O, Vlotides G, Fukuoka H, <i> et al.</i>: Expression and function of ErbB receptors and ligands in the pituitary. <i>Endocr Relat Cancer.</i> 2011; <b>18</b>(6): R197211. <a target=xrefwindow id=d8163e1790 href="http://www.ncbi.nlm.nih.gov/pubmed/21917845">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1793 href="http://dx.doi.org/10.1530/ERC-11-0066">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1797 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3758362">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d8163e1807 class=n-a></a>Pivonello R, Petersenn S, Newell-Price J, <i> et al.</i>: Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. <i>Clin Endocrinol (Oxf).</i> 2014; <b>81</b>(3): 40817. <a target=xrefwindow id=d8163e1818 href="http://www.ncbi.nlm.nih.gov/pubmed/24533697">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1821 href="http://dx.doi.org/10.1111/cen.12431">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d8163e1830 class=n-a></a>Weikum ER, Knuesel MT, Ortlund EA, <i> et al.</i>: Glucocorticoid receptor control of transcription: precision and plasticity via allostery. <i>Nat Rev Mol Cell Biol.</i> 2017; <b>18</b>(3): 15974. <a target=xrefwindow id=d8163e1841 href="http://www.ncbi.nlm.nih.gov/pubmed/28053348">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1844 href="http://dx.doi.org/10.1038/nrm.2016.152">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732845652"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1853 class=n-a></a>Sesta A, Cassarino MF, Cavagnini F, <i> et al.</i>: Role of the ubiquitin/proteasome system on ACTH turnover in rat corticotropes. <i>Endocrine.</i> 2018; <b>61</b>(3): 511517. <a target=xrefwindow id=d8163e1864 href="http://www.ncbi.nlm.nih.gov/pubmed/29536250">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1867 href="http://dx.doi.org/10.1007/s12020-018-1573-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732845652">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725464879"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1880 class=n-a></a>Perez-Rivas LG, Theodoropoulou M, Ferra F, <i> et al.</i>: The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease. <i>J Clin Endocrinol Metab.</i> 2015; <b>100</b>(7): E9971004. <a target=xrefwindow id=d8163e1891 href="http://www.ncbi.nlm.nih.gov/pubmed/25942478">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1894 href="http://dx.doi.org/10.1210/jc.2015-1453">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1898 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4490309">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725464879">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727615020"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1911 class=n-a></a>Faucz FR, Tirosh A, Tatsi C, <i> et al.</i>: Somatic <i>USP8</i> Gene Mutations Are a Common Cause of Pediatric Cushing Disease. <i>J Clin Endocrinol Metab.</i> 2017; <b>102</b>(8): 283643. <a target=xrefwindow id=d8163e1925 href="http://www.ncbi.nlm.nih.gov/pubmed/28505279">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1929 href="http://dx.doi.org/10.1210/jc.2017-00161">Publisher Full Text </a> | <a target=xrefwindow id=d8163e1932 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5546857">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727615020">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d8163e1945 class=n-a></a>Prez-Rivas LG, Theodoropoulou M, Puar TH, <i> et al.</i>: Somatic <i>USP8</i> mutations are frequent events in corticotroph tumor progression causing Nelson's tumor. <i>Eur J Endocrinol.</i> 2018; <b>178</b>(1): 5965. <a target=xrefwindow id=d8163e1959 href="http://www.ncbi.nlm.nih.gov/pubmed/28982703">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1963 href="http://dx.doi.org/10.1530/EJE-17-0634">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d8163e1973 class=n-a></a>Albani A, Prez-Rivas LG, Dimopoulou C, <i> et al.</i>: The <i>USP8</i> mutational status may predict long-term remission in patients with Cushing's disease. <i>Clin Endocrinol (Oxf).</i> 2018. <a target=xrefwindow id=d8163e1984 href="http://www.ncbi.nlm.nih.gov/pubmed/29957855">PubMed Abstract </a> | <a target=xrefwindow id=d8163e1987 href="http://dx.doi.org/10.1111/cen.13802">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727137312"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e1996 class=n-a></a>Sbiera S, Tryfonidou MA, Weigand I, <i> et al.</i>: Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas. <i>PLoS One.</i> 2016; <b>11</b>(2): e0169009. <a target=xrefwindow id=d8163e2007 href="http://www.ncbi.nlm.nih.gov/pubmed/28005997">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2010 href="http://dx.doi.org/10.1371/journal.pone.0169009">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2014 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5179081">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727137312">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727614420"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2027 class=n-a></a>Uzilov AV, Cheesman KC, Fink MY, <i> et al.</i>: Identification of a novel <i>RASD1</i> somatic mutation in a <i>USP8</i>-mutated corticotroph adenoma. <i>Cold Spring Harb Mol Case Stud.</i> 2017; <b>3</b>(3): a001602. <a target=xrefwindow id=d8163e2045 href="http://www.ncbi.nlm.nih.gov/pubmed/28487882">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2048 href="http://dx.doi.org/10.1101/mcs.a001602">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2051 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5411693">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727614420">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d8163e2064 class=n-a></a>Karl M, Von Wichert G, Kempter E, <i> et al.</i>: Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. <i>J Clin Endocrinol Metab.</i> 1996; <b>81</b>(1): 1249. <a target=xrefwindow id=d8163e2075 href="http://www.ncbi.nlm.nih.gov/pubmed/8550738">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2078 href="http://dx.doi.org/10.1210/jcem.81.1.8550738">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727642242"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2087 class=n-a></a>Hernndez-Ramrez LC, Gam R, Valds N, <i> et al.</i>: Loss-of-function mutations in the <i>CABLES1</i> gene are a novel cause of Cushing's disease. <i>Endocr Relat Cancer.</i> 2017; <b>24</b>(8): 37992. <a target=xrefwindow id=d8163e2101 href="http://www.ncbi.nlm.nih.gov/pubmed/28533356">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2105 href="http://dx.doi.org/10.1530/ERC-17-0131">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2108 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5510591">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727642242">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d8163e2121 class=n-a></a>Zhou Y, Zhang X, Klibanski A: Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. <i>Mol Cell Endocrinol.</i> 2014; <b>386</b>(12): 1633. <a target=xrefwindow id=d8163e2129 href="http://www.ncbi.nlm.nih.gov/pubmed/24035864">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2132 href="http://dx.doi.org/10.1016/j.mce.2013.09.006">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2135 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3943596">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727821250"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2145 class=n-a></a>Ezzat S, Cheng S, Asa SL: Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications. <i>Mol Cell Endocrinol.</i> 2018; <b>469</b>: 706. <a target=xrefwindow id=d8163e2153 href="http://www.ncbi.nlm.nih.gov/pubmed/28711607">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2156 href="http://dx.doi.org/10.1016/j.mce.2017.07.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727821250">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1049222"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2169 class=n-a></a>Bilodeau S, Vallette-Kasic S, Gauthier Y, <i> et al.</i>: Role of Brg1 and HDAC2 in GR <i>trans</i>-repression of the pituitary <i>POMC</i> gene and misexpression in Cushing disease. <i>Genes Dev.</i> 2006; <b>20</b>(20): 287186. <a target=xrefwindow id=d8163e2187 href="http://www.ncbi.nlm.nih.gov/pubmed/17043312">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2190 href="http://dx.doi.org/10.1101/gad.1444606">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2193 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1619949">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1049222">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727615013"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2206 class=n-a></a>Lu J, Chatain GP, Bugarini A, <i> et al.</i>: Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease. <i>J Clin Endocrinol Metab.</i> 2017; <b>102</b>(8): 282535. <a target=xrefwindow id=d8163e2217 href="http://www.ncbi.nlm.nih.gov/pubmed/28505327">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2220 href="http://dx.doi.org/10.1210/jc.2017-00464">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2224 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5546859">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727615013">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d8163e2237 class=n-a></a>Hinton DR, Hahn JA, Weiss MH, <i> et al.</i>: Loss of Rb expression in an ACTH-secreting pituitary carcinoma. <i>Cancer Lett.</i> 1998; <b>126</b>(2): 20914. <a target=xrefwindow id=d8163e2248 href="http://www.ncbi.nlm.nih.gov/pubmed/9585068">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2251 href="http://dx.doi.org/10.1016/S0304-3835(98)00013-5">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d8163e2260 class=n-a></a>Wierinckx A, Roche M, Legras-Lachuer C, <i> et al.</i>: MicroRNAs in pituitary tumors. <i>Mol Cell Endocrinol.</i> 2017; <b>456</b>: 5161. <a target=xrefwindow id=d8163e2271 href="http://www.ncbi.nlm.nih.gov/pubmed/28089822">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2274 href="http://dx.doi.org/10.1016/j.mce.2017.01.021">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d8163e2283 class=n-a></a>Zhang T, Yang Z, Gao H: Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomas. <i>J Neurooncol.</i> 2017; <b>134</b>(2): 2538. <a target=xrefwindow id=d8163e2291 href="http://www.ncbi.nlm.nih.gov/pubmed/28577032">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2294 href="http://dx.doi.org/10.1007/s11060-017-2518-5">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2297 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5570781">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730374409"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2307 class=n-a></a>Wang Y, Yin X, Zhao L, <i> et al.</i>: MicroRNA-200b inhibits pituitary tumor cell proliferation and invasion by targeting PKC. <i>Exp Ther Med.</i> 2017; <b>14</b>(2): 170614. <a target=xrefwindow id=d8163e2318 href="http://www.ncbi.nlm.nih.gov/pubmed/28810639">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2321 href="http://dx.doi.org/10.3892/etm.2017.4681">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2325 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5526044">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730374409">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d8163e2338 class=n-a></a>Amaral FC, Torres N, Saggioro F, <i> et al.</i>: MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. <i>J Clin Endocrinol Metab.</i> 2009; <b>94</b>(1): 3203. <a target=xrefwindow id=d8163e2349 href="http://www.ncbi.nlm.nih.gov/pubmed/18840638">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2352 href="http://dx.doi.org/10.1210/jc.2008-1451">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727543158"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2361 class=n-a></a>Garbicz F, Mehlich D, Rak B, <i> et al.</i>: Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology. <i>Pituitary.</i> 2017; <b>20</b>(4): 45063. <a target=xrefwindow id=d8163e2372 href="http://www.ncbi.nlm.nih.gov/pubmed/28432562">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2375 href="http://dx.doi.org/10.1007/s11102-017-0805-y">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2379 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5508039">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727543158">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d8163e2392 class=n-a></a>Gentilin E, Tagliati F, Filieri C, <i> et al.</i>: miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase C. <i>Endocrinology.</i> 2013; <b>154</b>(5): 1690700. <a target=xrefwindow id=d8163e2403 href="http://www.ncbi.nlm.nih.gov/pubmed/23525216">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2406 href="http://dx.doi.org/10.1210/en.2012-2070">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2410 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3695590">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d8163e2419 class=n-a></a>Smith SM, Vale WW: The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. <i>Dialogues Clin Neurosci.</i> 2006; <b>8</b>(4): 38395. <a target=xrefwindow id=d8163e2427 href="http://www.ncbi.nlm.nih.gov/pubmed/17290797">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2430 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3181830">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d8163e2439 class=n-a></a>Karl M, Lamberts SW, Koper JW, <i> et al.</i>: Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. <i>Proc Assoc Am Physicians.</i> 1996; <b>108</b>(4): 296307. <a target=xrefwindow id=d8163e2450 href="http://www.ncbi.nlm.nih.gov/pubmed/8863343">PubMed Abstract </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d8163e2460 class=n-a></a>Dahia PL, Honegger J, Reincke M, <i> et al.</i>: Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. <i>J Clin Endocrinol Metab.</i> 1997; <b>82</b>(4): 108893. <a target=xrefwindow id=d8163e2471 href="http://www.ncbi.nlm.nih.gov/pubmed/9100578">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2474 href="http://dx.doi.org/10.1210/jcem.82.4.3861">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718018313"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2483 class=n-a></a>Du L, Bergsneider M, Mirsadraei L, <i> et al.</i>: Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(21): 855560. <a target=xrefwindow id=d8163e2494 href="http://www.ncbi.nlm.nih.gov/pubmed/23653479">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2497 href="http://dx.doi.org/10.1073/pnas.1306182110">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2501 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3666748">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718018313">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726394622"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2514 class=n-a></a>Zhang D, Du L, Heaney AP: Testicular Receptor-4: Novel Regulator of Glucocorticoid Resistance. <i>J Clin Endocrinol Metab.</i> 2016; <b>101</b>(8): 312333. <a target=xrefwindow id=d8163e2522 href="http://www.ncbi.nlm.nih.gov/pubmed/27253665">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2525 href="http://dx.doi.org/10.1210/jc.2016-1379">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726394622">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726818228"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2538 class=n-a></a>Zhang D, Bergsneider M, Wang MB, <i> et al.</i>: Targeting the ERK pathway for the treatment of Cushing's disease. <i>Oncotarget.</i> 2016; <b>7</b>(43): 6914958. <a target=xrefwindow id=d8163e2549 href="http://www.ncbi.nlm.nih.gov/pubmed/27708250">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2552 href="http://dx.doi.org/10.18632/oncotarget.12381">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2556 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5342466">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726818228">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718458814"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2569 class=n-a></a>Kirschke E, Goswami D, Southworth D, <i> et al.</i>: Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles. <i>Cell.</i> 2014; <b>157</b>(7): 168597. <a target=xrefwindow id=d8163e2580 href="http://www.ncbi.nlm.nih.gov/pubmed/24949977">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2583 href="http://dx.doi.org/10.1016/j.cell.2014.04.038">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2587 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4087167">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718458814">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d8163e2600 class=n-a></a>Kang KI, Meng X, Devin-Leclerc J, <i> et al.</i>: The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. <i>Proc Natl Acad Sci U S A.</i> 1999; <b>96</b>(4): 143944. <a target=xrefwindow id=d8163e2611 href="http://www.ncbi.nlm.nih.gov/pubmed/9990042">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2614 href="http://dx.doi.org/10.1073/pnas.96.4.1439">Publisher Full Text </a> | <a target=xrefwindow id=d8163e2618 href="http://www.ncbi.nlm.nih.gov/pmc/articles/15481">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1007643"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2628 class=n-a></a>Freeman BC, Yamamoto KR: Disassembly of transcriptional regulatory complexes by molecular chaperones. <i>Science.</i> 2002; <b>296</b>(5576): 22325. <a target=xrefwindow id=d8163e2636 href="http://www.ncbi.nlm.nih.gov/pubmed/12077419">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2639 href="http://dx.doi.org/10.1126/science.1073051">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1007643">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725346876"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2652 class=n-a></a>Riebold M, Kozany C, Freiburger L, <i> et al.</i>: A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease. <i>Nat Med.</i> 2015; <b>21</b>(3): 27680. <a target=xrefwindow id=d8163e2663 href="http://www.ncbi.nlm.nih.gov/pubmed/25665180">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2666 href="http://dx.doi.org/10.1038/nm.3776">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725346876">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d8163e2679 class=n-a></a>Saller R, Meier R, Brignoli R: The use of silymarin in the treatment of liver diseases. <i>Drugs.</i> 2001; <b>61</b>(4): 203563. <a target=xrefwindow id=d8163e2687 href="http://www.ncbi.nlm.nih.gov/pubmed/11735632">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2690 href="http://dx.doi.org/10.2165/00003495-200161140-00003">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d8163e2699 class=n-a></a>Assi G, Bahurel H, Bertherat J, <i> et al.</i>: The Nelson's syndrome... revisited. <i>Pituitary.</i> 2004; <b>7</b>(4): 20915. <a target=xrefwindow id=d8163e2710 href="http://www.ncbi.nlm.nih.gov/pubmed/16132203">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2713 href="http://dx.doi.org/10.1007/s11102-005-1403-y">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d8163e2722 class=n-a></a>Patel J, Eloy JA, Liu JK: Nelson's syndrome: a review of the clinical manifestations, pathophysiology, and treatment strategies. <i>Neurosurg Focus.</i> 2015; <b>38</b>(2): E14. <a target=xrefwindow id=d8163e2730 href="http://www.ncbi.nlm.nih.gov/pubmed/25639316">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2733 href="http://dx.doi.org/10.3171/2014.10.FOCUS14681">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1063912"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2742 class=n-a></a>Assi G, Bahurel H, Coste J, <i> et al.</i>: Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome. <i>J Clin Endocrinol Metab.</i> 2007; <b>92</b>(1): 1729. <a target=xrefwindow id=d8163e2753 href="http://www.ncbi.nlm.nih.gov/pubmed/17062771">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2756 href="http://dx.doi.org/10.1210/jc.2006-1328">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1063912">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d8163e2770 class=n-a></a>Kemink SA, Wesseling P, Pieters GF, <i> et al.</i>: Progression of a Nelson's adenoma to pituitary carcinoma; a case report and review of the literature. <i>J Endocrinol Invest.</i> 1999; <b>22</b>(1): 705. <a target=xrefwindow id=d8163e2781 href="http://www.ncbi.nlm.nih.gov/pubmed/10090141">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2784 href="http://dx.doi.org/10.1007/BF03345482">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d8163e2793 class=n-a></a>Oldfield EH, Vance ML, Louis RG, <i> et al.</i>: Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility. <i>J Clin Endocrinol Metab.</i> 2015; <b>100</b>(8): 316571. <a target=xrefwindow id=d8163e2804 href="http://www.ncbi.nlm.nih.gov/pubmed/26147609">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2807 href="http://dx.doi.org/10.1210/JC.2015-2493">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733849791"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2816 class=n-a></a>Kurowska M, Tarach JS, Malicka J, <i> et al.</i>: Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment. <i>Endokrynol Pol.</i> 2016; <b>67</b>(5): 52633. <a target=xrefwindow id=d8163e2827 href="http://www.ncbi.nlm.nih.gov/pubmed/27828691">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2830 href="http://dx.doi.org/10.5603/EP.2016.0060">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733849791">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d8163e2843 class=n-a></a>Tateno T, Izumiyama H, Doi M, <i> et al.</i>: Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. <i>Eur J Endocrinol.</i> 2007; <b>157</b>(6): 71724. <a target=xrefwindow id=d8163e2854 href="http://www.ncbi.nlm.nih.gov/pubmed/18057378">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2857 href="http://dx.doi.org/10.1530/EJE-07-0428">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d8163e2866 class=n-a></a>Kovacs K, Horvath E, Bayley TA, <i> et al.</i>: Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. <i>Am J Med.</i> 1978; <b>64</b>(3): 4929. <a target=xrefwindow id=d8163e2877 href="http://www.ncbi.nlm.nih.gov/pubmed/76447">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2880 href="http://dx.doi.org/10.1016/0002-9343(78)90236-X">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d8163e2889 class=n-a></a>Tateno T, Izumiyama H, Doi M, <i> et al.</i>: Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma. <i>Endocr J.</i> 2007; <b>54</b>(5): 77782. <a target=xrefwindow id=d8163e2900 href="http://www.ncbi.nlm.nih.gov/pubmed/17917309">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2903 href="http://dx.doi.org/10.1507/endocrj.K07-059">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726617152"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2913 class=n-a></a>Righi A, Faustini-Fustini M, Morandi L, <i> et al.</i>: The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3. <i>Endocrine.</i> 2017; <b>56</b>(2): 28697. <a target=xrefwindow id=d8163e2924 href="http://www.ncbi.nlm.nih.gov/pubmed/27491554">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2927 href="http://dx.doi.org/10.1007/s12020-016-1028-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726617152">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d8163e2940 class=n-a></a>Roncaroli F, Scheithauer BW, Young WF, <i> et al.</i>: Silent corticotroph carcinoma of the adenohypophysis: a report of five cases. <i>Am J Surg Pathol.</i> 2003; <b>27</b>(4): 47786. <a target=xrefwindow id=d8163e2951 href="http://www.ncbi.nlm.nih.gov/pubmed/12657932">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2954 href="http://dx.doi.org/10.1097/00000478-200304000-00007">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726348399"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e2963 class=n-a></a>He L, Forbes JA, Carr K, <i> et al.</i>: Response of silent corticotroph pituitary carcinoma to chemotherapy: case report. <i>J Neurosurg Sci.</i> 2016; <b>60</b>(2): 27280. <a target=xrefwindow id=d8163e2974 href="http://www.ncbi.nlm.nih.gov/pubmed/27150544">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726348399">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d8163e2987 class=n-a></a>Cohen AB, Lessell S: Angiogenesis and pituitary tumors. <i>Semin Ophthalmol.</i> 2009; <b>24</b>(3): 1859. <a target=xrefwindow id=d8163e2995 href="http://www.ncbi.nlm.nih.gov/pubmed/19437356">PubMed Abstract </a> | <a target=xrefwindow id=d8163e2998 href="http://dx.doi.org/10.1080/08820530902805651">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d8163e3007 class=n-a></a>Lloyd RV, Vidal S, Horvath E, <i> et al.</i>: Angiogenesis in normal and neoplastic pituitary tissues. <i>Microsc Res Tech.</i> 2003; <b>60</b>(2): 24450. <a target=xrefwindow id=d8163e3018 href="http://www.ncbi.nlm.nih.gov/pubmed/12539179">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3021 href="http://dx.doi.org/10.1002/jemt.10263">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d8163e3030 class=n-a></a>Schito L, Semenza GL: Hypoxia-Inducible Factors: Master Regulators of Cancer Progression. <i>Trends Cancer.</i> 2016; <b>2</b>(12): 75870. <a target=xrefwindow id=d8163e3038 href="http://www.ncbi.nlm.nih.gov/pubmed/28741521">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3041 href="http://dx.doi.org/10.1016/j.trecan.2016.10.016">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d8163e3051 class=n-a></a>Koyasu S, Kobayashi M, Goto Y, <i> et al.</i>: Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge. <i>Cancer Sci.</i> 2018; <b>109</b>(3): 56071. <a target=xrefwindow id=d8163e3062 href="http://www.ncbi.nlm.nih.gov/pubmed/29285833">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3065 href="http://dx.doi.org/10.1111/cas.13483">Publisher Full Text </a> | <a target=xrefwindow id=d8163e3069 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5834787">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d8163e3078 class=n-a></a>Troilo A, Alexander I, Muehl S, <i> et al.</i>: HIF1 deubiquitination by USP8 is essential for ciliogenesis in normoxia. <i>EMBO Rep.</i> 2014; <b>15</b>(1): 7785. <a target=xrefwindow id=d8163e3089 href="http://www.ncbi.nlm.nih.gov/pubmed/24378640">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3092 href="http://dx.doi.org/10.1002/embr.201337688">Publisher Full Text </a> | <a target=xrefwindow id=d8163e3096 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4303451">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d8163e3105 class=n-a></a>Carbia-Nagashima A, Gerez J, Perez-Castro C, <i> et al.</i>: RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. <i>Cell.</i> 2007; <b>131</b>(2): 30923. <a target=xrefwindow id=d8163e3116 href="http://www.ncbi.nlm.nih.gov/pubmed/17956732">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3119 href="http://dx.doi.org/10.1016/j.cell.2007.07.044">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d8163e3128 class=n-a></a>Shan B, Gerez J, Haedo M, <i> et al.</i>: RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells. <i>Endocr Relat Cancer.</i> 2012; <b>19</b>(1): 1327. <a target=xrefwindow id=d8163e3139 href="http://www.ncbi.nlm.nih.gov/pubmed/22009797">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3142 href="http://dx.doi.org/10.1530/ERC-11-0211">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726428814"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3151 class=n-a></a>Liu HY, Gu WJ, Wang CZ, <i> et al.</i>: Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(23): e3904. <a target=xrefwindow id=d8163e3162 href="http://www.ncbi.nlm.nih.gov/pubmed/27310993">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3165 href="http://dx.doi.org/10.1097/MD.0000000000003904">Publisher Full Text </a> | <a target=xrefwindow id=d8163e3169 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4998479">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726428814">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733849792"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3182 class=n-a></a>Liu X, Feng M, Zhang Y, <i> et al.</i>: Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence. <i>World Neurosurg.</i> 2018; <b>113</b>: e213e221. <a target=xrefwindow id=d8163e3193 href="http://www.ncbi.nlm.nih.gov/pubmed/29432944">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3196 href="http://dx.doi.org/10.1016/j.wneu.2018.01.214">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733849792">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d8163e3210 class=n-a></a>Mete O, Ezzat S, Asa SL: Biomarkers of aggressive pituitary adenomas. <i>J Mol Endocrinol.</i> 2012; <b>49</b>(2): R6978. <a target=xrefwindow id=d8163e3218 href="http://www.ncbi.nlm.nih.gov/pubmed/22822048">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3221 href="http://dx.doi.org/10.1530/JME-12-0113">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d8163e3230 class=n-a></a>Hui P, Xu X, Xu L, <i> et al.</i>: Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis. <i>Int J Clin Exp Pathol.</i> 2015; <b>8</b>(4): 355667. <a target=xrefwindow id=d8163e3241 href="http://www.ncbi.nlm.nih.gov/pubmed/26097538">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3244 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4466925">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727121127"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3253 class=n-a></a>He W, Huang L, Shen X, <i> et al.</i>: Relationship between RSUME and HIF-1/VEGF-A with invasion of pituitary adenoma. <i>Gene.</i> 2017; <b>603</b>: 5460. <a target=xrefwindow id=d8163e3264 href="http://www.ncbi.nlm.nih.gov/pubmed/27989771">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3267 href="http://dx.doi.org/10.1016/j.gene.2016.12.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727121127">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d8163e3280 class=n-a></a>Seltzer J, Ashton CE, Scotton TC, <i> et al.</i>: Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature. <i>Neurosurg Focus.</i> 2015; <b>38</b>(2): E17. <a target=xrefwindow id=d8163e3291 href="http://www.ncbi.nlm.nih.gov/pubmed/25639319">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3294 href="http://dx.doi.org/10.3171/2014.10.FOCUS14683">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726837395"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3303 class=n-a></a>Lan X, Gao H, Wang F, <i> et al.</i>: Whole-exome sequencing identifies variants in invasive pituitary adenomas. <i>Oncol Lett.</i> 2016; <b>12</b>(4): 231928. <a target=xrefwindow id=d8163e3314 href="http://www.ncbi.nlm.nih.gov/pubmed/27698795">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3317 href="http://dx.doi.org/10.3892/ol.2016.5029">Publisher Full Text </a> | <a target=xrefwindow id=d8163e3321 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5038494">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726837395">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727566856"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3334 class=n-a></a>de Arajo LJ, Lerario AM, de Castro M, <i> et al.</i>: Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas. <i>Front Endocrinol (Lausanne).</i> 2017; <b>8</b>: 55. <a target=xrefwindow id=d8163e3345 href="http://www.ncbi.nlm.nih.gov/pubmed/28382019">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3348 href="http://dx.doi.org/10.3389/fendo.2017.00055">Publisher Full Text </a> | <a target=xrefwindow id=d8163e3352 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5360720">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727566856">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727765189"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3366 class=n-a></a>Liu B, Pang B, Wang Q, <i> et al.</i>: EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas. <i>Hum Pathol.</i> 2017; <b>66</b>: 1017. <a target=xrefwindow id=d8163e3377 href="http://www.ncbi.nlm.nih.gov/pubmed/28666925">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3380 href="http://dx.doi.org/10.1016/j.humpath.2017.03.028">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727765189">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d8163e3393 class=n-a></a>Renjie W, Haiqian L: MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5. <i>Cancer Lett.</i> 2015; <b>356</b>(2 Pt B): 56878. <a target=xrefwindow id=d8163e3401 href="http://www.ncbi.nlm.nih.gov/pubmed/25305447">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3404 href="http://dx.doi.org/10.1016/j.canlet.2014.10.003">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733849794"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3413 class=n-a></a>Zheng Z, Zhang Y, Zhang Z, <i> et al.</i>: Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT. <i>Med Sci Monit.</i> 2017; <b>23</b>: 127785. <a target=xrefwindow id=d8163e3424 href="http://www.ncbi.nlm.nih.gov/pubmed/28288092">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3427 href="http://dx.doi.org/10.12659/MSM.900092">Publisher Full Text </a> | <a target=xrefwindow id=d8163e3431 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5360419">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733849794">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733393640"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3444 class=n-a></a>Trouillas J, Burman P, McCormack A, <i> et al.</i>: Aggressive pituitary tumours and carcinomas: Two sides of the same coin? <i>Eur J Endocrinol.</i> 2018; <b>178</b>(6): C7C9. <a target=xrefwindow id=d8163e3455 href="http://www.ncbi.nlm.nih.gov/pubmed/29588294">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3458 href="http://dx.doi.org/10.1530/EJE-18-0250">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733393640">F1000 Recommendation</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727674855"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3471 class=n-a></a>Lasolle H, Cortet C, Castinetti F, <i> et al.</i>: Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas. <i>Eur J Endocrinol.</i> 2017; <b>176</b>(6): 76977. <a target=xrefwindow id=d8163e3482 href="http://www.ncbi.nlm.nih.gov/pubmed/28432119">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3485 href="http://dx.doi.org/10.1530/EJE-16-0979">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727674855">F1000 Recommendation</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727073986"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3498 class=n-a></a>Yang Z, Zhang T, Gao H: Genetic aspects of pituitary carcinoma: A systematic review. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(47): e5268. <a target=xrefwindow id=d8163e3506 href="http://www.ncbi.nlm.nih.gov/pubmed/27893664">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3509 href="http://dx.doi.org/10.1097/MD.0000000000005268">Publisher Full Text </a> | <a target=xrefwindow id=d8163e3512 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5134857">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727073986">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d8163e3526 class=n-a></a>Stilling G, Sun Z, Zhang S, <i> et al.</i>: MicroRNA expression in ACTH-producing pituitary tumors: Up-regulation of microRNA-122 and -493 in pituitary carcinomas. <i>Endocrine.</i> 2010; <b>38</b>(1): 6775. <a target=xrefwindow id=d8163e3537 href="http://www.ncbi.nlm.nih.gov/pubmed/20960104">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3540 href="http://dx.doi.org/10.1007/s12020-010-9346-0">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727261370"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3549 class=n-a></a>Dai C, Sun B, Liu X, <i> et al.</i>: O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysis. <i>Oncotarget.</i> 2017; <b>8</b>(12): 1967483. <a target=xrefwindow id=d8163e3560 href="http://www.ncbi.nlm.nih.gov/pubmed/28152515">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3563 href="http://dx.doi.org/10.18632/oncotarget.14936">Publisher Full Text </a> | <a target=xrefwindow id=d8163e3567 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5386713">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727261370">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d8163e3580 class=n-a></a>Takeshita A, Inoshita N, Taguchi M, <i> et al.</i>: High incidence of low O<sup>6</sup>-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease. <i>Eur J Endocrinol.</i> 2009; <b>161</b>(4): 5539. <a target=xrefwindow id=d8163e3594 href="http://www.ncbi.nlm.nih.gov/pubmed/19589911">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3598 href="http://dx.doi.org/10.1530/EJE-09-0414">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d8163e3607 class=n-a></a>Salehi F, Scheithauer BW, Moyes VJ, <i> et al.</i>: Low immunohistochemical expression of MGMT in ACTH secreting pituitary tumors of patients with Nelson syndrome. <i>Endocr Pathol.</i> 2010; <b>21</b>(4): 2279. <a target=xrefwindow id=d8163e3618 href="http://www.ncbi.nlm.nih.gov/pubmed/21061089">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3621 href="http://dx.doi.org/10.1007/s12022-010-9138-3">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d8163e3630 class=n-a></a>Salehi F, Scheithauer BW, Kovacs K, <i> et al.</i>: O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas. <i>Neurosurgery.</i> 2012; <b>70</b>(2): 4916; discussion 496. <a target=xrefwindow id=d8163e3641 href="http://www.ncbi.nlm.nih.gov/pubmed/21822153">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3644 href="http://dx.doi.org/10.1227/NEU.0b013e318230ac63">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732011891"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8163e3653 class=n-a></a>Raverot G, Burman P, McCormack A, <i> et al.</i>: European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. <i>Eur J Endocrinol.</i> 2018; <b>178</b>(1): G1G24. <a target=xrefwindow id=d8163e3664 href="http://www.ncbi.nlm.nih.gov/pubmed/29046323">PubMed Abstract </a> | <a target=xrefwindow id=d8163e3667 href="http://dx.doi.org/10.1530/EJE-17-0796">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732011891">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Aug 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1354&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1354&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany<br/> <p> <div class=margin-bottom> Ulrich Renner <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation </div> <div class=margin-bottom> Denis Ciato <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> G&uuml;nter K. Stalla <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1354/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Aug 2018, 7:1354 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14789.1">https://doi.org/10.12688/f1000research.14789.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Renner U <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=16094 data-id=14789 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14789.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1354/v1/pdf?article_uuid=f527abc7-792b-45e5-8880-857ab84c732a" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14789.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Renner U, Ciato D and Stalla GK. Recent advances in understanding corticotroph pituitary tumor initiation and progression [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1354 (<a href="https://doi.org/10.12688/f1000research.14789.1" target=_blank>https://doi.org/10.12688/f1000research.14789.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14789 id=mobile-track-article-signin-14789 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14789?target=/articles/7-1354"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16094 /> <input name=articleId type=hidden value=14789 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Francesca Pecori Giraldi</strong>, University of Milan, Istituto Auxologico Italiano, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Xavier Bertagna</strong>, Faculte de Medicine Paris-Descartes, Universite Paris, France </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Aug 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1354&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1354&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=38326-37538></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=38324-37539></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1354/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Aug 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Francesca Pecori Giraldi</strong>, University of Milan, Istituto Auxologico Italiano, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Xavier Bertagna</strong>, Faculte de Medicine Paris-Descartes, Universite Paris, France </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1354&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1354/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding corticotroph...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1354/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1354/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1354/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Renner U et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1354/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1354",
            templates : {
                twitter : "Recent advances in understanding corticotroph pituitary tumor.... Renner U et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1354/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding corticotroph pituitary tumor initiation and progression", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding corticotroph pituitary tumor initiation and progression", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14789/16094")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "16094");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "37538": 0,
                           "37539": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "1ccfb307-8885-4b99-a522-1a6861756e06";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1354.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1354.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1354.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1354.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1354.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>